Angina does run in families, and the inherited component is larger than many people realize. Twin studies estimate that roughly 40% of the variation in who develops angina can be attributed to genetics, with the remaining 60% driven by environment and lifestyle. But “hereditary” in this context does not mean a single gene hands you a diagnosis the way cystic fibrosis or sickle cell disease might. For most people, the genetic contribution to angina comes from dozens or hundreds of small-effect gene variants working together, layered on top of shared family habits and a few powerful single-gene conditions that affect a smaller slice of the population.
How Much of Angina Risk Is Genetic
The clearest window into heritability comes from twin studies, which compare identical twins (who share all their DNA) with fraternal twins (who share about half). A Swedish twin study found that the heritability of angina pectoris was about 0.39 in men and 0.43 in women, meaning genetic factors account for close to 40% of the variation in risk for both sexes. The same study found that angina and death from coronary heart disease share overlapping genetic pathways, which is why a family history of angina is treated as a warning sign for heart disease more broadly.1PubMed. Genetic influences on angina pectoris and its impact on coronary heart disease
The coronary arteries themselves also show strong genetic fingerprints. A classical twin study using cardiac CT imaging found that coronary artery calcification, one of the structural changes that narrows arteries and causes angina, had a heritability of about 58%. Calcified plaque volume was even more heritable, at roughly 78%.2PubMed Central. Heritability of Coronary Artery Disease: Insights From a Classical Twin Study In practical terms, the tendency for calcium and plaque to build up in your coronary arteries is substantially shaped by your DNA, which is a major reason why angina clusters in families.
The Many-Gene Picture
For the vast majority of people, angina risk is polygenic, meaning it comes from many genetic variants scattered across the genome, each contributing a tiny nudge toward higher or lower risk. Researchers combine these into a single number called a polygenic risk score. In large studies, each standard-deviation increase in a coronary artery disease polygenic risk score raised the risk of future heart attack by about 20 to 32%, and higher scores also tracked with more severe artery blockages as measured by angiography.3PubMed Central. Polygenic Risk and Coronary Artery Disease Severity4PubMed. Predictive Accuracy of a Polygenic Risk Score–Enhanced Prediction Model vs a Clinical Risk Score for Coronary Artery Disease
These scores are genuinely useful, but they are not crystal balls. When added to traditional clinical risk calculators, a polygenic risk score improved the ability to identify who would go on to have a cardiovascular event. One UK study found the combination flagged nearly 69% of future cases as high-risk, compared with about 62% using clinical factors alone. The improvement was especially pronounced in younger adults under 55, where clinical risk scores tend to underestimate danger because the person has not yet accumulated high blood pressure or cholesterol readings.5European Heart Journal. Polygenic risk score adds to a clinical risk score in the prediction of cardiovascular disease in a clinical setting
Single-Gene Conditions That Dramatically Raise Risk
A small but important fraction of angina cases trace back to a single powerful gene variant rather than a crowd of small ones. The most common example is familial hypercholesterolemia (FH), an inherited condition that impairs the body’s ability to clear LDL cholesterol from the bloodstream. People with a monogenic form of FH, where one identifiable mutation is responsible, face about double the risk of cardiovascular disease compared with people whose high cholesterol has no detectable genetic cause. When a monogenic FH mutation combines with an unfavorable set of smaller polygenic variants, that risk roughly triples.6PubMed. Risk of Premature Atherosclerotic Disease in Patients With Monogenic Versus Polygenic Familial Hypercholesterolemia
FH is not rare. Among young adults who showed up to hospitals with acute coronary syndrome (heart attacks and unstable angina), clinically defined FH was present in about 1 in 11 patients. Those patients were harder to treat: at one year of follow-up, only about 18% of FH patients hit cholesterol targets compared with roughly 56% of patients without FH, and their rate of major cardiovascular and cerebrovascular events was significantly higher.7PubMed. Familial Hypercholesterolemia Among Young Adults With Acute Coronary Syndrome This matters because FH is often undiagnosed. If your parent or sibling had a heart attack or developed angina unusually young, FH screening is worth discussing with a doctor.
Lipoprotein(a) and the Risk You Cannot Diet Away
One inherited risk factor that gets far less attention than cholesterol is lipoprotein(a), often written as Lp(a). Your Lp(a) level is almost entirely determined by genetics, and it does not respond meaningfully to diet or standard statin therapy. Elevated Lp(a) is considered the most common monogenic lipid disorder worldwide, and genetic studies have firmly established it as an independent risk factor for cardiovascular disease.8PubMed Central. Cardiovascular Implications of Lipoprotein(a) and its Genetic Variants: A Critical Review From the Middle East
A large genome-wide association study identified two common variants in the gene encoding Lp(a) that individually raised coronary disease risk by 70% and 92%. Carrying both variants more than doubled the risk. When the analysis adjusted for actual Lp(a) blood levels, the genetic association disappeared entirely, confirming that the gene variants cause disease specifically by raising Lp(a) concentration.9PubMed. Genetic variants associated with Lp(a) lipoprotein level and coronary disease Lp(a) is measured with a simple blood test, yet many people have never had it checked. If you have a family history of early heart disease and your standard cholesterol panel looks normal, an elevated Lp(a) level could be the hidden factor. New drugs targeting Lp(a) are currently in late-stage clinical trials, which may eventually give people a pharmacological tool for a risk factor that lifestyle changes cannot touch.
Angina That Is Not From Plaque Buildup
Not all angina comes from clogged arteries. Two major subtypes, vasospastic angina (where coronary arteries suddenly constrict) and microvascular angina (where the tiniest blood vessels in the heart do not dilate properly), also show evidence of genetic influence, though the research is less mature.
A nationwide Swedish family study found that people who had a sibling with vasospastic angina faced more than double the risk of developing it themselves compared with the general population. Spouses of affected individuals showed no increased risk, which argues against shared household exposures like secondhand smoke or cooking habits and points toward a genetic component.10PubMed Central. Familial risk of vasospastic angina: a nationwide family study in Sweden
Microvascular angina has its own emerging genetic story. A specific gene variant (rs9349379) that regulates the production of endothelin-1, a molecule that constricts blood vessels, has been linked to coronary microvascular dysfunction. Patients carrying the risk version of that variant had more than double the odds of microvascular dysfunction.11European Heart Journal. Genetic dysregulation of endothelin-1 is implicated in coronary microvascular dysfunction This finding is especially interesting because it is leading directly toward targeted treatment: a clinical trial is testing an endothelin receptor blocker specifically in microvascular angina patients, with the gene variant used to predict who is most likely to respond.12American Heart Journal / Elsevier. Rationale and design of the Medical Research Council’s Precision Medicine with Zibotentan in Microvascular Angina (PRIZE) trial This is one of the clearest examples of genetics potentially guiding angina treatment in the near future.
Lifestyle Can Cut Through Even High Genetic Risk
One of the most reassuring findings in cardiovascular genetics is that a healthy lifestyle provides protection even when your DNA is working against you. A landmark study pooling data from multiple large cohorts found that among people in the highest genetic risk category for coronary artery disease, those who maintained a favorable lifestyle (not smoking, healthy weight, regular exercise, and a good diet) had a 46% lower relative risk of coronary events compared with those with an unfavorable lifestyle. In concrete terms, the ten-year risk of a coronary event in one cohort dropped from roughly 11% to about 5% with lifestyle alone.13PubMed Central. Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease
This is not a case of genetics being irrelevant. A person at high genetic risk who lives perfectly still faces higher absolute risk than someone at low genetic risk living the same way. But the lifestyle effect is large enough to shift many high-risk people into the zone of people at moderate genetic risk who live poorly. Genes load the gun; habits pull the trigger, as the cliché goes, and for once the cliché captures the data pretty well.
How Your Parents’ Environment Can Affect Your Arteries
Beyond the DNA sequence itself, there is growing evidence that environmental exposures in previous generations can alter how genes are expressed in offspring, through chemical modifications to DNA that do not change the underlying code. The most dramatic historical example comes from the Dutch Hunger Winter of 1944-1945: the children of women who were pregnant during the famine showed altered DNA methylation patterns decades later, and those children went on to develop coronary artery disease earlier than expected.14Medical Epigenetics. Epigenetics of Cardiovascular Disease: A New ‘Beat’ in Coronary Artery Disease
More recent research has moved from historical observation to molecular prediction. A study analyzing blood samples from thousands of participants identified over 50 specific sites in the genome where methylation patterns predicted future heart attacks and coronary heart disease. Many of these sites mapped to genes involved in calcium regulation, which is directly relevant to how plaque forms in arteries.15PubMed. Blood Leukocyte DNA Methylation Predicts Risk of Future Myocardial Infarction and Coronary Heart Disease This means that some of your heart disease risk may reflect not just your own genes and habits, but the environmental stresses your parents or grandparents experienced. It also complicates the simple nature-versus-nurture framing: what looks like an environmental effect in one generation can behave like a heritable trait in the next.
Which Parent Matters More
When doctors ask about family history, they typically ask about both parents. But the data suggest that paternal versus maternal inheritance of heart disease risk is not identical. In families carrying familial hypercholesterolemia mutations, patients who inherited FH from their father developed their first cardiovascular event about four years earlier on average than those who inherited it from their mother, at age 42 versus 46. Before age 50, paternal inheritance carried about 1.5 times the risk of cardiovascular disease compared with maternal inheritance.16PubMed. Paternal inheritance predicts earlier cardiovascular event onset in patients with familial hypercholesterolemia
The reasons are not fully understood. One explanation is that fathers with FH may have had less aggressive lipid treatment historically, so they passed on both the genetic variant and a family culture with less awareness of the risk. Another possibility involves biological differences in how maternal versus paternal gene copies are expressed. Either way, if your father had a heart attack young, that deserves particular attention in your own risk planning.
What Family History Means at the Doctor’s Office
Clinically, a “positive family history” for heart disease usually means a first-degree relative (parent or sibling) who developed cardiovascular disease before age 55 in men or 65 in women.17PubMed Central. Family history of cardiovascular disease and risk of premature coronary heart disease: A matched case-control study Some calculators use a threshold of 50 or 60 rather than 55, so the exact cutoff varies.18PubMed Central. Association between family history and coronary heart disease death across long-term follow-up in men: the Cooper Center Longitudinal Study19PubMed Central. Evaluation of cardiovascular diseases risk calculators for CVDs prevention and management: scoping review
The value of actually collecting this information systematically was demonstrated in a UK trial where primary care practices were randomized to either collect structured family history questionnaires or continue with their usual approach. In the practices that collected detailed family histories, the proportion of patients reclassified as high cardiovascular risk jumped by nearly 5 percentage points compared with controls. That reclassification matters because it can trigger earlier statin therapy, blood pressure management, or further testing.20PubMed. Effect of adding systematic family history enquiry to cardiovascular disease risk assessment in primary care: a matched-pair, cluster randomized trial
In practice, many people have only a vague sense of their family cardiac history. “My dad had a heart problem” is less useful than knowing whether it was angina, a heart attack, a bypass surgery, and at what age. If you are putting together your own family history for a medical visit, try to pin down the specific diagnosis and the age at onset for each affected relative. The earlier the onset, the more relevant it is to your genetic risk.
Genetic Risk Across Different Populations
Most of the large genetic studies on coronary artery disease have been conducted in people of European descent, which raises a legitimate concern about whether polygenic risk scores work equally well in everyone. Research involving multiple ancestry groups found that while the scores do predict risk across populations, the strength of prediction varies. The odds ratio per standard deviation of a coronary disease score ranged from about 1.47 in people of American genetic ancestry to 1.81 in people of South Asian ancestry.21Nature Communications. Ancestry-specific polygenic risk scores are risk enhancers for clinical cardiovascular disease assessments The direction of risk is consistent, but the magnitude differs, which means polygenic risk scores calibrated in one population should not be applied blindly to another.
Work is underway to develop ancestry-specific scores and to include more diverse populations in the foundational genetic databases. Until that work matures, the practical takeaway is that a positive family history remains the most universally reliable genetic signal across all populations, regardless of whether your ancestry is well represented in genome-wide studies.
Cascade Screening in Families
When a genetic condition like familial hypercholesterolemia is identified in one person, the standard recommendation is cascade screening: testing that person’s close relatives to see who else carries the variant. Inherited cardiovascular diseases affect an estimated 1 to 2% of the global population, and cascade testing is considered valuable because effective prevention and treatment exist for many of these conditions. However, real-world uptake remains modest. About 40% of at-risk relatives undergo genetic counseling and testing within a year of the initial diagnosis, and long-term uptake stays incomplete.22Europe PMC. Cascade genetic counseling and testing in hereditary syndromes: inherited cardiovascular disease as a model: a narrative review
The barriers are mostly psychological and logistical, not medical. Some family members do not want to know. Others live far from specialized centers. And the conversation itself is awkward: telling a sibling they might carry a mutation that raises their heart disease risk is not easy dinner-table talk. Despite these hurdles, cascade screening for FH is one of the few genetic interventions with a clear cost-effectiveness case, because identifying and treating elevated LDL early can prevent heart attacks decades down the line.
Does Learning Your Genetic Risk Change Behavior
An understandable worry is that telling someone they have a high genetic risk for heart disease might cause anxiety or, paradoxically, fatalistic thinking along the lines of “why bother if it’s in my genes?” The evidence so far is largely reassuring on the psychological side. A systematic review found that receiving genetic cardiovascular risk information produced no significant changes in anxiety or depression scores over six to twelve months of follow-up.23European Journal of Preventive Cardiology. Impact of genetic risk information for cardiovascular disease on behavioural changes, psychological responses and risk factor modification: a systematic review
The behavior change picture is more mixed. Some studies show modest improvements in diet or physical activity after genetic risk disclosure, but the effects tend to be small and short-lived. Genetic risk information does not reliably motivate the kind of sustained lifestyle overhaul that would actually bend the risk curve. What it can do is prompt a conversation with a doctor that leads to medication, earlier screening, or more aggressive cholesterol management, which are the interventions with the strongest evidence behind them.
Why Coronary Artery Disease Persists in the Human Gene Pool
If genes that raise heart disease risk are so common, you might wonder why natural selection has not weeded them out. The answer appears to be a tradeoff. A study examining genetic variants associated with coronary artery disease found that many of these same variants are also linked to traits related to reproductive success, like fertility and the number of offspring. The relationship is antagonistic: the genetic variants that raise your risk of coronary disease in later life appear to offer some advantage for reproduction earlier in life.24PLOS Genetics. Genetic loci associated with coronary artery disease harbor evidence of selection and antagonistic pleiotropy Natural selection operates most strongly on traits that affect survival and reproduction before and during the reproductive years. A gene variant that boosts fertility at 25 but raises heart attack risk at 60 faces very little evolutionary pressure to disappear, because most of its carriers have already passed it on.